![Ellen Cavaleri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ellen Cavaleri
Investor Relations Kontakt bei
PTC THERAPEUTICS, INC.
Profil
Ellen Cavaleri is currently Head-Investor Relations at PTC Therapeutics, Inc. since 2024.
Formerly, worked as Senior VP-Investor Relations & Communications at Lyra Therapeutics, Inc. from 2022 to 2024, and served as Investor Relations Contact at Kadmon Holdings, Inc. Education includes an undergraduate degree from Vanderbilt University and an MBA from New York University.
Aktive Positionen von Ellen Cavaleri
| Unternehmen | Position | Beginn |
|---|---|---|
| PTC THERAPEUTICS, INC. | Investor Relations Kontakt | 01.11.2024 |
Ehemalige bekannte Positionen von Ellen Cavaleri
| Unternehmen | Position | Ende |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Investor Relations Kontakt | 01.06.2024 |
| KADMON HOLDINGS, INC. | Investor Relations Kontakt | - |
Ausbildung von Ellen Cavaleri
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
